FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017838975> ?p ?o ?g. }

• W2017838975 endingPage "6337" @default.
• W2017838975 startingPage "6330" @default.
• W2017838975 abstract "Abstract Immunophenotypic classification of acute lymphoblastic leukemia (ALL) has well-recognized prognostic implications. The significance of CD20 expression has been evaluated in childhood precursor B-lineage ALL with conflicting results. We retrospectively analyzed the influence of CD20 expression on outcome in 253 adults with de novo precursor B-lineage ALL treated with either conventional (VAD/CVAD) or intensive (hyper-CVAD) frontline chemotherapy regimens in the pre-rituximab era. Overall, CD20 positivity of at least 20% was associated with lower 3-year rates of complete remission duration (CRD; 20% vs 55%, P < .001) and overall survival (OS; 27% vs 40%, p = .03). In the CD20 negative subset, the 3-year rates for CRD (58% vs 42%, p = .04) and OS (60% vs 28%, P < .001) were superior for hyper-CVAD compared with VAD/CVAD; rates were particularly favorable for the CD20 negative younger age group (68% and 85%, respectively). In contrast, 3-year CRD and OS rates were uniformly poor for the CD20-positive group regardless of therapy (27% or less). Multivariate analysis for event-free survival identified older age, leukocyte count higher than 30 × 109/L, presence of Philadelphia chromosome, high systemic risk classification, and CD20 positivity as independent predictors of worse outcome. In conclusion, CD20 expression in de novo adult precursor B-lineage ALL appears to be associated with a poor prognosis. Incorporation of monoclonal antibodies directed against CD20 into frontline chemotherapy regimens warrants investigation." @default.
• W2017838975 created "2016-06-24" @default.
• W2017838975 creator A5006075699 @default.
• W2017838975 creator A5015140142 @default.
• W2017838975 creator A5027575595 @default.
• W2017838975 creator A5028026524 @default.
• W2017838975 creator A5028591457 @default.
• W2017838975 creator A5030500582 @default.
• W2017838975 creator A5038307470 @default.
• W2017838975 creator A5045950634 @default.
• W2017838975 creator A5046097970 @default.
• W2017838975 creator A5061026876 @default.
• W2017838975 creator A5084455291 @default.
• W2017838975 creator A5085521139 @default.
• W2017838975 creator A5090435894 @default.
• W2017838975 date "2009-06-18" @default.
• W2017838975 modified "2023-10-15" @default.
• W2017838975 title "Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia" @default.
• W2017838975 cites W148262973 @default.
• W2017838975 cites W1834314364 @default.
• W2017838975 cites W1862517694 @default.
• W2017838975 cites W1975280591 @default.
• W2017838975 cites W199452398 @default.
• W2017838975 cites W2005004376 @default.
• W2017838975 cites W2066823421 @default.
• W2017838975 cites W2117634410 @default.
• W2017838975 cites W2119661337 @default.
• W2017838975 cites W2125134816 @default.
• W2017838975 cites W2132433919 @default.
• W2017838975 cites W2139499066 @default.
• W2017838975 cites W2142998407 @default.
• W2017838975 cites W2167548316 @default.
• W2017838975 cites W2586133727 @default.
• W2017838975 cites W4293241248 @default.
• W2017838975 doi "https://doi.org/10.1182/blood-2008-04-151860" @default.
• W2017838975 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2943753" @default.
• W2017838975 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18703706" @default.
• W2017838975 hasPublicationYear "2009" @default.
• W2017838975 type Work @default.
• W2017838975 sameAs 2017838975 @default.
• W2017838975 citedByCount "176" @default.
• W2017838975 countsByYear W20178389752012 @default.
• W2017838975 countsByYear W20178389752013 @default.
• W2017838975 countsByYear W20178389752014 @default.
• W2017838975 countsByYear W20178389752015 @default.
• W2017838975 countsByYear W20178389752016 @default.
• W2017838975 countsByYear W20178389752017 @default.
• W2017838975 countsByYear W20178389752018 @default.
• W2017838975 countsByYear W20178389752019 @default.
• W2017838975 countsByYear W20178389752020 @default.
• W2017838975 countsByYear W20178389752021 @default.
• W2017838975 countsByYear W20178389752022 @default.
• W2017838975 countsByYear W20178389752023 @default.
• W2017838975 crossrefType "journal-article" @default.
• W2017838975 hasAuthorship W2017838975A5006075699 @default.
• W2017838975 hasAuthorship W2017838975A5015140142 @default.
• W2017838975 hasAuthorship W2017838975A5027575595 @default.
• W2017838975 hasAuthorship W2017838975A5028026524 @default.
• W2017838975 hasAuthorship W2017838975A5028591457 @default.
• W2017838975 hasAuthorship W2017838975A5030500582 @default.
• W2017838975 hasAuthorship W2017838975A5038307470 @default.
• W2017838975 hasAuthorship W2017838975A5045950634 @default.
• W2017838975 hasAuthorship W2017838975A5046097970 @default.
• W2017838975 hasAuthorship W2017838975A5061026876 @default.
• W2017838975 hasAuthorship W2017838975A5084455291 @default.
• W2017838975 hasAuthorship W2017838975A5085521139 @default.
• W2017838975 hasAuthorship W2017838975A5090435894 @default.
• W2017838975 hasBestOaLocation W20178389751 @default.
• W2017838975 hasConcept C126322002 @default.
• W2017838975 hasConcept C143998085 @default.
• W2017838975 hasConcept C18031839 @default.
• W2017838975 hasConcept C203014093 @default.
• W2017838975 hasConcept C2776694085 @default.
• W2017838975 hasConcept C2778461978 @default.
• W2017838975 hasConcept C2779338263 @default.
• W2017838975 hasConcept C2780653079 @default.
• W2017838975 hasConcept C2781107101 @default.
• W2017838975 hasConcept C2909962599 @default.
• W2017838975 hasConcept C71924100 @default.
• W2017838975 hasConceptScore W2017838975C126322002 @default.
• W2017838975 hasConceptScore W2017838975C143998085 @default.
• W2017838975 hasConceptScore W2017838975C18031839 @default.
• W2017838975 hasConceptScore W2017838975C203014093 @default.
• W2017838975 hasConceptScore W2017838975C2776694085 @default.
• W2017838975 hasConceptScore W2017838975C2778461978 @default.
• W2017838975 hasConceptScore W2017838975C2779338263 @default.
• W2017838975 hasConceptScore W2017838975C2780653079 @default.
• W2017838975 hasConceptScore W2017838975C2781107101 @default.
• W2017838975 hasConceptScore W2017838975C2909962599 @default.
• W2017838975 hasConceptScore W2017838975C71924100 @default.
• W2017838975 hasIssue "25" @default.
• W2017838975 hasLocation W20178389751 @default.
• W2017838975 hasLocation W20178389752 @default.
• W2017838975 hasLocation W20178389753 @default.
• W2017838975 hasLocation W20178389754 @default.
• W2017838975 hasOpenAccess W2017838975 @default.
• W2017838975 hasPrimaryLocation W20178389751 @default.
• W2017838975 hasRelatedWork W1603245933 @default.

• next